ABBV vs ERNA · P/E 81, rev $61.16B vs P/E 0.0, rev $582.0K
AbbVie Inc (ABBV) versus Eterna Therapeutics Inc (ERNA) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
Latest reported ABBV revenue for 2025-12-31 was $61.16B. Net income was $4.23B. Revenue was up 305.0% from 2024-12-31 to 2025-12-31. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Not investment advice. Open the ABBV and ERNA stock pages for the full models.
Not investment advice.